Concepedia

Yoichi Nagata

YN

Statistics

Publications

11

Citations

2.5K

H-Index

10

Active since

1987

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Kurume University

Kumamoto University

Yoichi Nagata is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, life sciences, and oncology.

Publications per year

1987–2015

11

Publications

11

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

Yoichi Nagata, Keng‐Hsueh Lan, Xiaoyan Zhou et al. · Cancer Cell · 2004 · 1.9K citations · Full text

, , +14

Phosphorylation on Tyrosine-15 of p34Cdc2 by ErbB2 Inhibits p34Cdc2 Activation and Is Involved in Resistance to Taxol-Induced Apoptosis

Ming Tan, Keng‐Hsueh Lan, Christopher L. Neal et al. · Molecular Cell · 2002 · 129 citations · Full text

, , +16

Combined trastuzumab and paclitaxel treatment better inhibits ErbB‐2‐mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone

Kristine S. Klos, Xiaoyan Zhou, Sangkyou Lee et al. · Cancer · 2003 · 110 citations · Full text

, , +17

ErbB2 Promotes Src Synthesis and Stability: Novel Mechanisms of Src Activation That Confer Breast Cancer Metastasis

Ming Tan, Ping Li, Kristine S. Klos et al. · Cancer Research · 2005 · 106 citations · Full text

, , +17

The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association

Yoichi Nagata, Tadashi Anan, Tetsuo Yoshida et al. · Oncogene · 1999 · 101 citations

, , +11

1–5 of 11